This is a non-core endpoint: only basic statistics are computed.
Hepatocellular carcinoma
C3_HEPATOCELLU_CARC
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1003 |
4. Check minimum number of eventsNone |
1003 |
5. Include endpointsNone |
1003 |
6. Filter based on genotype QC (FinnGen only) |
881 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Hepatocellular carcinoma
based on the number of shared cases.
Similar with more cases:
- Hepatocellular carcinoma, including Hilmo
- Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo
- Malignant neoplasm of digestive organs
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 881 | 149 | 732 |
| Unadjusted period prevalence (%) | 0.29 | 0.05 | 0.34 |
| Median age at first event (years) | 73.01 | 74.51 | 72.70 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 917
- Matched controls
- 9170
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
307.7
677
*
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
49.4
307.7
228
61
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
307.7
882
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
158.0
307.7
320
31
Z51.5
ICD-10 Finland
Palliative care
26.6
307.7
388
246
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
426
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
294.2
307.7
324
17
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
14.2
288.4
315
327
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
35.3
286.4
187
66
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
53.1
267.1
155
35
198
Kela drug reimbursment
Sorafenib
+∞
244.0
223
*
JN4CD
NOMESCO Finland
Very extensive body CT
40.2
239.6
149
44
A03FA01
ATC
metoclopramide; systemic, rectal
10.6
236.3
323
449
N02AA05
ATC
oxycodone; systemic
8.3
223.6
437
910
R18
ICD-10 Finland
Ascites
31.3
220.2
148
56
8000/3-C22.0
ICD-O-3
Neoplasm, malignant of liver
+∞
216.5
199
*
JN4AD
NOMESCO Finland
Body CT examination
10.1
181.1
238
308
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
29.9
177.0
120
46
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
177.0
164
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
31.9
173.7
115
41
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
27.9
147.5
102
41
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
20.3
143.0
113
63
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
15.6
129.3
117
85
L01XE05
ATC
[U] sorafenib
+∞
129.3
121
*
323
Kela drug reimbursment
Sorafenib
+∞
128.2
120
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.1
125.5
270
583
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
13.9
124.8
121
99
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
117.3
110
*
A04AA01
ATC
ondansetron; systemic, rectal
18.8
113.2
92
54
C03DA01
ATC
spironolactone; oral
5.0
111.9
332
938
127
Kela drug reimbursment
Transplant complication
30.4
109.5
73
26
WX302
NOMESCO Finland
Thoracal epidural anesthesy
14.4
107.5
101
78
JN4BD
NOMESCO Finland
Extensive body CT
8.6
104.2
145
196
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.3
95.4
155
249
JN3AD
NOMESCO Finland
Abdominal CT examination
5.3
95.1
234
559
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
+∞
94.4
89
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.9
89.5
442
1768
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
89.0
84
*
L04AA06
ATC
mycophenolic acid; systemic
19.2
88.7
71
40
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
88.0
83
*
WZC00
NOMESCO Finland
Treatment plan or consultation
4.0
87.7
378
1375
C61
ICD-10 Finland
Malignant neoplasm of prostate
321.6
87.3
87
*
H02AB02
ATC
dexamethasone; systemic
16.7
86.3
74
48
L04AD02
ATC
tacrolimus; systemic
34.4
85.9
55
17
L01EX02
ATC
sorafenib; oral
+∞
82.6
78
*
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
+∞
77.2
73
*
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
29.0
77.0
52
19
3019
Kela drug reimbursment
Lenvatinib
+∞
76.1
72
*
1508
Kela drug reimbursment
Lenvatinib
+∞
74.0
70
*
Z94.4
ICD-10 Finland
Liver transplant status
203.9
73.3
75
*
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
33.0
72.6
47
15
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
+∞
70.8
67
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
32.2
70.5
46
15
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
27.5
68.4
47
18
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
65.4
62
*
L01EX08
ATC
lenvatinib; oral
+∞
65.4
62
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
345.6
65.3
65
*
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
10.5
63.2
72
74
A06AD11
ATC
lactulose; oral
3.5
62.9
289
1063
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
120.3
62.7
67
6
103
Kela drug reimbursment
Diabetes, insulin-treated
3.1
62.7
463
2256
XX3DW
NOMESCO Finland
Time consuming IT work
6.7
61.1
104
173
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
19.8
60.0
47
25
WF002
NOMESCO Finland
Radical radiotherapy
86.0
57.8
64
8
K76.9
ICD-10 Finland
Liver disease, unspecified
16.3
55.8
48
31
A10BA02
ATC
metformin; oral
2.9
55.6
463
2368
A04AA02
ATC
granisetron; systemic, transdermal
293.2
54.8
55
*
K92.0
ICD-10 Finland
Haematemesis
6.9
53.8
87
137
A10AE04
ATC
insulin glargine; parenteral
3.8
53.7
197
619
C03CA01
ATC
furosemide; systemic
2.9
53.3
520
2873
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.8
50.7
415
2078
B18.2
ICD-10 Finland
Chronic viral hepatitis C
20.3
50.5
39
20
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.9
50.1
369
1746
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
492.3
47.8
47
*
116
Kela drug reimbursment
Prostate cancer
+∞
47.3
45
*
176
Kela drug reimbursment
Regorafenib
+∞
47.3
45
*
A05AA02
ATC
ursodeoxycholic acid; oral
15.1
47.0
42
29
N02AX02
ATC
tramadol; systemic, rectal
2.6
44.0
481
2729
D77
ICPC
Malignant digestive neopl other/NOS
230.8
43.3
44
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.1
42.8
132
364
WF049
NOMESCO Finland
Radiotherapy of metastasis
437.0
42.5
42
*
WW500
NOMESCO Finland
Blood transfusion
8.2
42.5
58
75
T90
ICPC
Diabetes non-insulin dependent
2.6
41.3
364
1849
WZC30
NOMESCO Finland
Teaching
3.3
40.7
176
608
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
112.7
40.1
43
*
A10AB05
ATC
insulin aspart; parenteral
3.7
40.0
145
447
A07AA11
ATC
rifaximin; oral
76.7
39.3
44
6
369
Kela drug reimbursment
Regorafenib
+∞
37.8
36
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
11.3
37.5
40
37
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
11.0
36.9
40
38
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
36.7
170
610
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
34.6
33
*
PC2SC
NOMESCO Finland
Liver angiography with X-ray
+∞
34.6
33
*
B01AB10
ATC
tinzaparin; parenteral
3.7
34.6
120
358
L04AD01
ATC
ciclosporin; systemic
11.0
34.2
37
35
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.3
32.9
49
70
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
56.5
32.5
38
7
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
32.5
31
*
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
+∞
32.5
31
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
74.7
32.1
36
5
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
32.1
259
1238
A10BB12
ATC
glimepiride; oral
3.1
31.9
157
581
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.9
31.6
72
156
L01EX05
ATC
regorafenib; oral
+∞
31.4
30
*
A79
ICPC
Malignancy NOS
165.6
30.9
32
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
30.4
29
*
K92.1
ICD-10 Finland
Melaena
3.7
30.3
105
312
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
28.7
507
3327
UJF32
NOMESCO Finland
Coloscopy
2.3
28.5
281
1458
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.5
28.4
231
1100
J01MA12
ATC
levofloxacin; systemic
2.5
27.9
229
1094
L02AE02
ATC
leuprorelin; implant, parenteral
144.2
26.8
28
*
SPAT1262
SPAT
Handing over of treatment supplies
2.4
26.6
229
1116
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
53.4
26.4
31
6
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
26.3
163
679
A10AE05
ATC
insulin detemir; parenteral
3.6
26.2
94
285
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
26.2
25
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
26.2
25
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
26.2
25
*
I81
ICD-10 Finland
Portal vein thrombosis
24.9
25.8
36
15
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
138.9
25.7
27
*
K72.1
ICD-10 Finland
Chronic hepatic failure
138.9
25.7
27
*
K83.0
ICD-10 Finland
Cholangitis
7.3
25.6
38
54
C07AG02
ATC
carvedilol; oral
3.1
25.6
114
396
A10BH01
ATC
sitagliptin; oral
2.7
25.3
158
660
A02BC02
ATC
pantoprazole; systemic
2.2
25.1
626
4586
JJA44
NOMESCO Finland
Laparoscopic destruction of lesion of liver
+∞
25.1
24
*
C22
ICD-10 Finland
Malignant neoplasm of liver and intrahepatic bile ducts
+∞
25.1
24
*
WX402
NOMESCO Finland
General anaesthesia
2.5
24.9
188
861
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
256.8
24.8
25
*
TJA10
NOMESCO Finland
Laparocentesis
133.7
24.7
26
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
8.5
24.5
32
39
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.5
24.4
190
881
R4110
NOMESCO Finland
Physiotherapy
2.2
24.3
274
1488
D97
ICPC
Liver disease NOS
30.1
24.2
32
11
JJB30
NOMESCO Finland
Excision of two segments of liver
+∞
24.1
23
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
38.7
24.1
30
8
K83.1
ICD-10 Finland
Obstruction of bile duct
9.3
23.9
29
32
A10AC01
ATC
insulin (human); parenteral
2.8
23.7
129
501
B01AB04
ATC
dalteparin; parenteral
4.2
23.6
66
168
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
8.1
23.5
32
41
B01AB05
ATC
enoxaparin; parenteral
2.1
23.4
292
1647
TK800
NOMESCO Finland
Hemodialysis
5.9
23.1
42
74
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
+∞
23.0
22
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
23.0
22
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
235.6
22.7
23
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
22.0
21
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
21.8
226
1181
JJB71
NOMESCO Finland
Laparoscopic resection of liver
225.1
21.7
22
*
C22.7
ICD-10 Finland
Malignant neoplasm: Other specified carcinomas of liver
+∞
20.9
20
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
20.9
20
*
N02AA01
ATC
morphine; systemic, rectal
5.9
20.8
38
67
R4190
NOMESCO Finland
Nutritional therapy
5.9
20.8
38
67
160
Kela drug reimbursment
exenatide
5.1
20.1
43
88
C07AA05
ATC
propranolol; systemic
2.3
19.9
166
789
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
19.9
19
*
A10BX07
ATC
[U] liraglutide
6.6
19.7
32
50
JJA20
NOMESCO Finland
Open biopsy of liver
107.4
19.6
21
*
J01MA02
ATC
ciprofloxacin; systemic
1.9
19.4
396
2620
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.7
19.3
36
65
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
18.8
18
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
18.8
18
*
A06AH03
ATC
naloxegol; oral
19.2
18.7
28
15
WW200, ,
SPAT
0.4
18.5
82
1972
D13.4
ICD-10 Finland
Benign neoplasm: Liver
45.0
18.3
22
5
205
Kela drug reimbursment
Chronic hypertension
1.9
18.3
375
2472
JJ5AT, ,
NOMESCO Finland
+∞
17.8
17
*
L01XE21
ATC
[U] regorafenib
+∞
17.8
17
*
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
183.4
17.6
18
*
ZX120
NOMESCO Finland
Intravenous
2.9
17.5
86
315
A10BG03
ATC
pioglitazone; oral
3.9
17.4
52
139
R50.9
ICD-10 Finland
Fever, unspecified
2.3
17.3
155
757
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.1
17.1
73
246
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
16.9
142
674
A10BH05
ATC
linagliptin; oral
2.8
16.7
87
328
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
16.7
16
*
L02BB03
ATC
bicalutamide; oral
+∞
16.7
16
*
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.0
16.7
77
272
K70.0
ICD-10 Finland
Alcoholic fatty liver
7.4
16.6
24
33
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
16.2
151
748
KCD02
NOMESCO Finland
Transurethral resection of bladder
17.1
16.1
25
15
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.7
16.1
52
147
PC1BC
NOMESCO Finland
Extensive angiography of aorta and abdominal arteries
25.0
16.1
22
9
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
61.1
15.8
18
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
15.7
15
*
E66.00
ICD-10 Finland
Metabolic syndrome
3.0
15.6
70
243
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.5
15.5
55
165
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
162.7
15.5
16
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.6
15.0
93
383
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.7
14.7
47
132
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
14.6
14
*
UJK02
NOMESCO Finland
ERCP
4.2
14.6
39
96
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.8
14.3
294
1907
UJF30
NOMESCO Finland
Ileoscopy through colon
2.5
14.3
98
424
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
5.8
14.2
26
46
A10BX04
ATC
[U] exenatide
6.5
14.2
23
36
XW000
NOMESCO Finland
Bone marrow biopsy
3.9
14.0
41
108
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
17.9
13.9
21
12
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.3
13.7
108
497
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.2
13.7
54
174
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
15.0
13.6
22
15
ZX050
NOMESCO Finland
Stereotactic radiotherapy
76.3
13.6
15
*
JJA43
NOMESCO Finland
Destruction of lesion of liver
+∞
13.6
13
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
13.6
13
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
13.6
13
*
Y77
ICPC
Malignant neoplasm prostate
142.0
13.5
14
*
A41.8
ICD-10 Finland
Other specified sepsis
4.2
13.4
36
89
162
Kela drug reimbursment
liraglutide
5.4
13.3
26
49
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.8
13.3
69
260
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
40.7
13.2
16
*
XCK10
NOMESCO Finland
Photography of fundus of eye
2.2
13.2
114
546
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
17.0
13.0
20
12
XX4BW, ,
NOMESCO Finland
50.8
12.9
15
*
WVA20
NOMESCO Finland
Medicine administration
3.9
12.7
37
97
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
12.6
71
279
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.4
12.6
46
141
A10BB01
ATC
glibenclamide; oral
2.4
12.5
86
372
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
+∞
12.5
12
*
L01XE29
ATC
[U] lenvatinib
+∞
12.5
12
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
12.5
167
942
N05CF01
ATC
zopiclone; oral
1.7
12.2
305
2075
K29.6
ICD-10 Finland
Other gastritis
5.6
12.2
23
42
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
12.1
208
1270
JAH00
NOMESCO Finland
Laparotomy
4.0
12.1
34
87
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.4
11.9
63
1439
XX2RW, ,
NOMESCO Finland
12.7
11.7
20
16
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.5
11.6
40
118
A10BJ02
ATC
liraglutide; parenteral
3.7
11.5
37
104
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
3.6
11.5
38
109
K70.4
ICD-10 Finland
Alcoholic hepatic failure
13.8
11.5
19
14
L01BC06
ATC
capecitabine; oral
+∞
11.5
11
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
121.5
11.4
12
*
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
121.5
11.4
12
*
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
35.5
11.3
14
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
17.3
11.2
17
10
WPB10
NOMESCO Finland
Making a convalescent care decision
25.4
11.2
15
6
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.4
11.1
40
122
L04AX01
ATC
azathioprine; systemic
3.3
10.9
42
133
C10AA05
ATC
atorvastatin; oral
0.6
10.9
247
3514
J01FF01
ATC
clindamycin; systemic
1.7
10.6
233
1521
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.7
10.5
55
208
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
10.4
109
561
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
10.4
10
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.4
10
*
115
Kela drug reimbursment
Breast cancer
+∞
10.4
10
*
JJB40
NOMESCO Finland
Excision of segments II, III and IV of liver
+∞
10.4
10
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
10.4
10
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
10.4
10
*
Z2446
NOMESCO Finland
Social worker
2.6
10.4
60
239
ZZA00
NOMESCO Finland
Split skin graft
3.8
10.4
31
83
JAH01
NOMESCO Finland
Laparoscopy
3.8
10.4
31
83
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.8
10.3
50
182
C10AX09
ATC
ezetimibe; oral
0.4
10.3
53
1229
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
10.3
127
695
A10BD07
ATC
metformin and sitagliptin; systemic
2.6
10.2
60
241
ZX108
NOMESCO Finland
Inhalation
10.2
10.0
19
19
JKA20
NOMESCO Finland
Cholecystectomy
3.1
10.0
41
135
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
9.9
128
710
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.2
9.9
82
385
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
16.9
9.9
15
9
WPA13
NOMESCO Finland
Palliative consultation
20.3
9.8
14
7
SPAT1109
SPAT
Analgesia with portable analgesic pump
13.5
9.7
16
12
K72.9
ICD-10 Finland
Hepatic failure, unspecified
8.5
9.6
20
24
ZXE00
NOMESCO Finland
One hour or less
1.6
9.6
301
2145
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.8
9.5
49
184
E0000UV, ,
ATC
1.6
9.5
319
2307
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
101.0
9.4
10
*
Z3231
NOMESCO Finland
Registered nurse
1.7
9.4
222
1471
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.3
9.4
24
57
177
Kela drug reimbursment
Insulin glargine 300 U / ml
4.3
9.4
24
57
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
9.4
9
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
9.4
9
*
1550A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, primary
+∞
9.4
9
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
9.4
9
*
L04AH02
ATC
everolimus; oral
+∞
9.4
9
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
9.4
9
*
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
+∞
9.4
9
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
9.4
9
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.1
9.4
39
130
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
9.6
9.3
18
19
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
9.2
306
2205
K70.1
ICD-10 Finland
Alcoholic hepatitis
7.8
9.2
20
26
N06DX01
ATC
memantine; oral
0.3
9.1
23
759
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
11.6
9.1
16
14
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
37.1
9.0
11
*
B02AA02
ATC
tranexamic acid; systemic
2.3
9.0
68
307
Z2221
NOMESCO Finland
Medical doctor
1.7
9.0
202
1320
M04AA01
ATC
allopurinol; systemic
1.7
9.0
176
1109
K29.7
ICD-10 Finland
Gastritis, unspecified
2.9
9.0
42
150
K74.0
ICD-10 Finland
Hepatic fibrosis
18.8
8.9
13
7
ZX090
NOMESCO Finland
Other technic of radiotherapy
24.3
8.9
12
5
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
8.9
260
1815
K74.3
ICD-10 Finland
Primary biliary cirrhosis
12.7
8.9
15
12
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.5
8.8
56
234
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
10.8
8.8
16
15
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
10.8
8.8
16
15
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.7
8.8
48
186
L03AA13
ATC
pegfilgrastim; parenteral
50.5
8.7
10
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
50.5
8.7
10
*
K76.7
ICD-10 Finland
Hepatorenal syndrome
16.5
8.6
13
8
V03AE01
ATC
polystyrene sulfonate; oral
4.1
8.6
23
57
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
10.2
8.5
16
16
K76.89
ICD-10 Finland
Other specified diseases of liver
20.2
8.5
12
6
L04AA18
ATC
[U] everolimus
90.9
8.4
9
*
I85
ICD-10 Finland
Oesophageal varices
90.9
8.4
9
*
PC2DE
NOMESCO Finland
Ultrasound examination of liver vasculature with Doppler method
90.9
8.4
9
*
WPA43, ,
SPAT
90.9
8.4
9
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
90.9
8.4
9
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
8.4
84
425
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
8.3
8
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
8.3
8
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
8.3
8
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
8.3
8
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
8.3
8
*
JJB20
NOMESCO Finland
Excision of single segment of liver
+∞
8.3
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.3
8
*
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
4.1
8.3
22
54
E66.01
ICD-10 Finland
Obesity due to excess calories
2.3
8.2
60
267
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.8
8.2
41
152
D05AX52
ATC
calcipotriol, combinations; topical
2.5
8.1
51
212
XF612
NOMESCO Finland
Measurement of central venous pressure
33.7
8.1
10
*
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
33.7
8.1
10
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
8.0
619
5285
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
10.1
8.0
15
15
H02AB04
ATC
methylprednisolone; systemic
1.8
8.0
125
736
WX002
NOMESCO Finland
Sedation and analgesia
1.7
8.0
163
1036
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.7
7.9
42
161
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.1
7.8
21
52
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
10.9
7.8
14
13
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.3
7.8
59
267
G93.4
ICD-10 Finland
Encephalopathy, unspecified
9.5
7.8
15
16
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.2
7.7
64
301
WZC15, ,
NOMESCO Finland
45.4
7.7
9
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
45.4
7.7
9
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
45.4
7.7
9
*
R10.0
ICD-10 Finland
Acute abdomen
3.1
7.6
31
102
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.2
7.6
6
333
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
7.6
233
1637
ZXC40
NOMESCO Finland
Use of ultrasound
12.0
7.6
13
11
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
12.0
7.6
13
11
A10BH02
ATC
vildagliptin; oral
3.2
7.5
29
93
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.5
7.5
47
196
D69.5
ICD-10 Finland
Secondary thrombocytopenia
80.7
7.4
8
*
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.1
7.4
*
289
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
13.5
7.4
12
9
A10BB07
ATC
glipizide; oral
3.1
7.4
30
99
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.3
7.3
17
587
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.9
7.3
17
25
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
7.3
7
*
L02AE04
ATC
triptorelin; parenteral
+∞
7.3
7
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
7.3
7
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
7.3
7
*
EB1VA, ,
NOMESCO Finland
0.4
7.3
31
788
D02AE01
ATC
carbamide; topical
2.2
7.2
57
263
WPA11
NOMESCO Finland
Developing a plan for palliative care
30.3
7.2
9
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
30.3
7.2
9
*
I86.4
ICD-10 Finland
Gastric varices
30.3
7.2
9
*
C10AC01
ATC
colestyramine; oral
3.4
7.1
25
75
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
20.2
7.1
10
5
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.1
7.1
29
96
ZXC96
NOMESCO Finland
Robot assisted procedure
12.1
7.1
12
10
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
7.1
7.0
16
23
A10BG02
ATC
rosiglitazone; oral
3.4
7.0
25
76
H02AB06
ATC
prednisolone; systemic
1.5
7.0
392
3110
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
6.9
69
349
WX892
NOMESCO Finland
Monitored bed care
2.0
6.9
80
427
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.5
6.9
69
1265
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
13.9
6.9
11
8
UJD02
NOMESCO Finland
Gastroscopy
2.3
6.9
53
242
C10AA07
ATC
rosuvastatin; oral
0.6
6.9
151
2227
K51.5
ICD-10 Finland
Left sided colitis
3.3
6.9
25
77
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
8.3
6.8
14
17
A46
ICD-10 Finland
Erysipelas
1.6
6.8
157
1027
J01DB01
ATC
cefalexin; oral
1.5
6.8
645
5640
JCA20
NOMESCO Finland
Ligature of oesophageal varices
40.4
6.8
8
*
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
40.4
6.8
8
*
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
3.6
6.7
22
63
A10AB04
ATC
insulin lispro; parenteral
2.8
6.7
32
116
WX882
NOMESCO Finland
High dependency care
2.8
6.7
32
116
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.5
6.7
42
175
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.5
6.7
41
169
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
6.6
63
313
RS220, ,
NOMESCO Finland
6.0
6.6
17
29
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
6.6
182
1243
KGH10
NOMESCO Finland
Operation for phimosis
2.5
6.6
41
170
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.3
6.6
48
214
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.1
6.5
60
296
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
70.3
6.4
7
*
JJ1AT
NOMESCO Finland
Puncture of lesion of liver with ultrasound guidance
70.3
6.4
7
*
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.6
6.4
37
148
T48
ICPC
Metabolic, Clarification/discussion RFE/demand
14.4
6.4
10
7
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
6.4
129
816
P20
ICPC
Memory disturbance
0.5
6.3
72
1268
ZXD05
NOMESCO Finland
Urgent procedure
1.5
6.3
247
1820
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.3
6.3
44
193
A07AA09
ATC
vancomycin; oral
3.9
6.3
18
47
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.9
6.3
18
47
K70.2
ICD-10 Finland
Alcoholic fibrosis and sclerosis of liver
18.2
6.3
9
5
UJK12
NOMESCO Finland
Peroral cholangioscopy
18.2
6.3
9
5
N06DA02
ATC
donepezil; oral
0.3
6.3
19
568
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
+∞
6.3
6
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
6.3
6
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
6.3
6
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
6.3
6
*
C22.2
ICD-10 Finland
Malignant neoplasm: Hepatoblastoma
+∞
6.3
6
*
WPA16
NOMESCO Finland
Extensive demanding palliative symptom assessment and treatment
+∞
6.3
6
*
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.1
6.3
58
286
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
0.5
6.2
71
1251
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.4
6.2
41
175
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.1
6.2
58
287
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.0
6.2
70
372
A10BD03
ATC
metformin and rosiglitazone; systemic
3.0
6.2
26
88
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
7.7
6.1
13
17
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
6.1
64
330
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
12.6
6.1
10
8
D07AC01
ATC
betamethasone; topical
1.4
6.1
293
2245
C09BA02
ATC
enalapril and diuretics; systemic
1.8
6.0
94
553
M01AB01
ATC
indometacin; systemic, rectal
1.8
6.0
98
584
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
3.9
6.0
17
44
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
433
603
12.71
307.65
6.3
2.0
0.17
0.19
g/l
6.12
416
543
498
382
27.34
307.65
3.9
1.4
3.76
2.77
ug/l
2.18
430
285
294
189
22.42
307.65
5.5
2.2
43.96
35.76
umol/l
2.40
281
170
346
127
43.15
307.65
3.9
1.9
221.16
55.20
u/ml
0.64
314
97
197
81
30.70
286.61
2.1
1.8
64.88
41.70
u/ml
0.32
185
72
227
169
17.52
252.26
1.5
1.1
54.37
102.14
titre
1.02
16
14
169
85
24.15
225.98
1.3
1.0
1.63
1.56
g/l
0.67
163
77
375
753
7.73
195.54
12.6
2.2
15.96
9.82
umol/l
2.19
359
660
96
23
46.50
161.76
5.0
1.7
76.55
95.22
%
1.63
96
23
325
765
6.03
138.81
12.9
6.2
8.92
11.54
mmol/l
6.74
314
722
77
23
36.46
122.06
2.5
1.8
745.51
695.94
e6/l
0.04
55
17
96
53
20.11
121.69
1.4
1.1
—
—
—
0
0
69
21
35.45
108.62
2.4
1.7
1559.70
87900.46
e6/l
0.53
40
13
190
339
6.81
106.26
1.6
1.3
1.56
1.16
g/l
1.90
174
313
124
137
10.31
104.31
1.3
1.4
—
—
—
0
0
262
666
5.11
99.27
2.5
1.8
1.68
1.66
%
0.14
236
557
62
19
34.93
97.26
4.7
1.9
0.58
0.61
mmol/l
1.08
62
19
441
1706
4.05
94.98
17.8
3.9
73.39
80.32
%
7.78
432
1666
501
2131
3.98
93.59
14.0
2.6
63.17
36.24
u/l
6.35
491
1986
201
435
5.64
91.17
2.3
1.9
13.86
11.36
g/l
7.96
188
400
632
3190
4.16
90.71
18.3
3.9
31.57
34.97
g/l
37.00
612
2934
71
40
19.16
88.74
2.3
2.3
48.78
64.99
iu/ml
—
8
7
666
3528
4.24
88.03
26.8
4.0
22.26
13.39
umol/l
12.04
653
3332
89
7
140.59
84.62
5.5
3.0
1654.53
4.29
ug/l
—
89
7
85
80
11.61
79.57
1.3
1.3
143.76
163.42
au/ml
0.47
17
25
268
825
4.18
77.59
3.5
2.1
241.02
236.48
u/l
0.24
262
761
329
1169
3.83
77.56
5.6
2.6
0.76
0.83
mmol/l
16.62
316
1078
91
99
10.09
76.95
10.6
5.3
742.78
381.81
iu/ml
0.49
36
16
74
59
13.56
76.86
1.3
1.3
180.91
209.00
titre
—
11
10
50
19
27.78
73.00
1.9
1.2
9.36
11.75
g/l
0.57
39
11
475
2203
3.40
72.66
6.2
2.3
58.30
62.54
u/l
0.67
461
2028
320
1161
3.70
72.42
2.8
2.6
24.14
22.73
%
0.73
310
1069
144
284
5.83
71.49
3.1
1.6
0.19
0.36
mg/l
3.20
51
133
118
194
6.83
70.40
6.3
2.9
1.70
1.76
mg/l
0.27
110
166
86
98
9.58
70.14
1.4
1.3
—
23.32
—
0
5
84
97
9.43
67.79
1.3
1.2
351.76
254.38
u/ml
1.28
55
45
57
41
14.76
62.64
1.2
1.0
—
—
—
0
0
202
586
4.14
62.32
3.9
2.3
34.34
35.69
u/l
0.17
178
469
319
1258
3.36
61.90
2.8
2.6
2.29
2.22
g/l
1.33
300
1155
646
3890
3.24
58.52
26.0
20.5
1.29
1.41
inr
8.87
588
3304
323
1332
3.20
57.52
2.9
2.6
13.15
12.39
umol/l
0.95
307
1224
60
68
9.37
48.90
2.6
2.4
97.00
263.80
u/ml
—
5
10
344
1611
2.82
47.07
4.4
2.2
—
—
—
0
0
520
3023
2.66
45.80
5.2
2.5
—
—
estimate
—
0
0
578
3621
2.61
42.32
14.9
6.0
4.16
4.51
e9/l
2.81
527
3079
250
1047
2.91
41.49
8.3
5.1
1.09
1.02
mmol/l
1.64
235
960
604
4054
2.44
35.17
14.3
3.2
197.34
55.00
u/l
42.03
584
3709
88
212
4.49
33.93
2.1
1.7
—
—
—
0
0
227
1066
2.50
28.82
12.5
7.2
12.44
11.19
kpa
3.89
219
1023
196
862
2.62
28.52
13.8
8.0
116.23
122.53
g/l
3.79
191
846
226
1066
2.49
28.38
12.6
7.2
4.96
5.10
kpa
1.38
218
1025
209
951
2.55
28.33
13.2
7.3
96.32
94.61
%
3.88
203
916
38
15
26.35
27.66
1.1
1.1
—
—
—
0
0
29
27
11.06
26.99
1.7
1.4
—
—
—
0
0
221
1059
2.43
26.63
12.7
7.2
0.15
1.07
mmol/l
3.02
185
867
505
3381
2.10
26.29
12.5
5.9
1.18
1.20
mmol/l
5.44
491
3059
545
3762
2.11
26.04
12.0
6.2
1.19
1.20
mmol/l
6.56
477
3210
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
93
283
3.54
25.82
4.7
2.6
0.23
0.36
iu/ml
4.14
46
155
217
1045
2.41
25.78
1.8
1.2
4.43
2.95
g/l
10.44
185
578
142
569
2.77
24.61
3.8
2.4
64.06
60.84
ml/min/173m2
0.31
67
237
36
51
7.31
24.31
1.0
1.0
—
—
—
0
0
139
559
2.75
23.89
16.1
9.4
1.43
1.31
%
1.12
139
554
608
4451
2.09
23.81
14.5
5.0
7.80
6.95
mmol/l
10.74
592
4252
195
928
2.40
23.59
4.7
3.3
0.85
1.95
mmol/l
3.26
154
788
173
785
2.48
23.21
4.3
3.4
—
—
—
0
0
342
2098
2.00
21.43
4.3
3.2
1.12
0.42
e6/l
2.30
272
1549
230
1217
2.19
21.43
3.3
3.1
1.02
1.26
e6/l
0.46
132
616
675
5253
2.08
20.85
29.6
5.6
156.64
79.22
u/l
36.12
656
4887
127
523
2.66
20.71
1.9
1.6
—
—
—
0
0
236
1308
2.08
19.25
3.3
3.0
0.73
0.97
e6/l
1.20
141
711
96
362
2.85
18.49
2.0
1.7
1.56
2.03
ug/l
0.39
89
314
329
2077
1.91
18.34
3.2
2.3
3.89
2.77
mg/l
9.90
291
1758
30
48
6.43
18.10
1.4
1.3
15.79
25.15
ng/l
2.33
30
48
41
90
4.72
17.66
1.0
1.3
—
—
—
0
0
373
2482
1.85
17.42
4.5
3.3
79.98
106.13
e6/l
0.29
306
1908
338
2241
1.80
15.55
6.4
2.0
2.32
2.34
mmol/l
2.52
326
1933
243
1475
1.88
14.74
2.2
1.9
—
—
—
0
0
119
555
2.31
14.69
5.0
3.2
1.21
1.22
mmol/l
1.04
111
474
232
1401
1.88
14.24
6.0
2.1
2.50
2.44
mmol/l
8.40
220
1218
384
2728
1.70
13.34
5.2
3.8
69.47
116.12
e6/l
0.94
312
1970
184
1055
1.93
13.12
2.1
1.9
—
—
—
0
0
267
1726
1.77
12.94
3.7
2.5
4.89
3.77
e6/l
1.11
252
1569
174
2820
0.53
12.88
2.8
1.9
1.72
1.31
mmol/l
5.09
161
2307
395
2871
1.66
12.30
4.4
3.0
175.31
156.46
ug/l
0.73
372
2635
570
4587
1.64
11.52
5.5
4.5
424.80
1843.11
e6/l
—
10
85
188
1137
1.82
11.21
2.2
1.8
—
—
—
0
0
23
28
8.40
10.85
1.6
1.3
—
—
—
0
0
112
575
2.08
10.81
3.8
1.7
414.95
380.88
nmol/l
0.83
106
519
395
2963
1.59
10.26
5.0
4.3
12.63
7.81
mg/mmol
1.28
287
1962
286
1993
1.63
10.06
4.3
2.7
383.67
375.25
umol/l
0.56
254
1690
13
6
21.95
9.36
1.3
1.0
—
—
—
0
0
267
3634
0.63
9.24
3.7
4.1
22.73
24.22
%
0.81
118
1818
123
695
1.89
8.99
2.1
1.6
65.61
66.38
g/l
0.43
110
623
46
176
2.70
8.64
1.2
1.4
278.13
282.80
ug/g
0.05
25
111
383
2945
1.52
8.41
4.1
3.5
7.20
7.87
mmol/l
2.89
319
2488
15
14
10.87
8.31
1.5
1.4
90.67
163.93
nmol/l
0.43
15
14
176
2562
0.61
7.77
2.6
3.0
0.86
0.75
ug/l
0.72
115
1770
205
1402
1.60
7.49
2.7
1.7
3.15
1.44
mg/l
3.55
175
1110
7
0
+∞
7.30
4.0
0.0
—
—
—
0
0
83
443
1.96
7.18
1.6
1.5
—
—
—
0
0
103
591
1.84
7.16
8.6
6.7
23.13
24.60
mmol/l
2.60
98
568
43
178
2.49
6.94
1.4
1.5
—
—
—
0
0
18
31
5.90
6.94
2.3
1.5
—
—
—
0
0
41
166
2.54
6.93
1.6
1.4
—
—
—
0
0
11
8
13.90
6.90
2.2
1.0
—
—
—
0
0
97
553
1.84
6.88
1.8
1.7
—
—
—
0
0
131
817
1.70
6.84
3.1
3.4
225.33
273.13
ng/l
0.76
121
764
18
32
5.72
6.78
1.5
1.4
1.58
7.66
u/l
2.12
12
25
10
6
16.83
6.75
1.0
1.0
—
—
—
0
0
45
198
2.34
6.38
4.2
3.5
2.16
1.66
index
0.23
31
103
78
427
1.90
6.28
1.7
1.6
1.26
1.47
g/l
1.00
63
366
582
6533
0.70
5.99
6.6
5.6
4.02
4.27
mmol/l
7.54
533
6021
40
172
2.39
5.98
1.7
1.4
—
—
—
0
0
30
113
2.71
5.87
1.7
1.4
—
—
—
0
0
51
247
2.13
5.77
2.1
2.3
218.78
109.64
ug/min
0.48
34
153
24
81
3.02
5.72
1.8
1.5
—
—
—
0
0
580
6477
0.72
5.40
6.4
5.5
1.20
1.36
mmol/l
19.26
526
5913
605
6700
0.71
5.25
6.9
6.5
2.32
2.45
mmol/l
3.42
553
6143
376
4476
0.73
5.12
4.6
4.4
2.11
2.15
ug/l
0.07
312
4016
31
128
2.47
5.09
1.4
1.3
12.28
6.63
u/l
1.10
22
104
24
88
2.77
4.97
2.8
1.6
89.71
90.33
%
0.21
24
88
56
299
1.93
4.90
4.8
4.2
2.07
1.52
mmol/l
0.79
56
293
19
62
3.11
4.81
1.3
1.2
—
—
—
0
0
18
61
2.99
4.30
1.0
1.2
—
—
—
0
0
209
1594
1.40
4.26
1.9
1.8
1143.96
1134.86
nmol/l
0.05
156
1222
562
6226
0.75
4.25
5.7
4.7
1.44
1.28
mmol/l
3.99
509
5626
87
554
1.63
4.21
3.0
3.8
84.99
100.90
ng/l
1.33
80
468
602
6596
0.75
4.15
6.4
5.7
6.86
6.19
mmol/l
15.89
542
5949
223
1729
1.38
4.11
4.7
4.5
393.14
471.43
ng/l
0.19
198
1539
51
285
1.84
3.93
2.2
1.4
37.61
36.52
mg/l
0.09
40
240
34
166
2.09
3.85
1.7
1.5
—
—
—
0
0
51
287
1.82
3.85
2.2
1.4
51.15
45.79
mg/l
0.38
40
241
32
153
2.13
3.82
1.5
1.3
—
—
—
0
0
33
160
2.10
3.81
1.3
1.2
—
—
—
0
0
18
66
2.76
3.77
3.7
3.0
26.17
12.00
index
0.79
12
35
45
245
1.88
3.77
1.3
1.2
—
—
—
0
0
19
73
2.64
3.65
1.6
2.6
878.50
607.71
ml
1.69
12
48
16
56
2.89
3.64
1.8
1.5
—
—
—
0
0
9
17
5.34
3.51
3.8
1.8
0.78
1.18
%
—
9
17
160
1204
1.40
3.49
1.3
1.2
1.45
1.58
u/ml
0.11
35
319
24
106
2.30
3.48
1.8
2.3
106.54
105.55
mmol/l
0.55
24
106
24
106
2.30
3.48
1.8
2.3
4.26
4.10
mmol/l
0.88
24
106
45
253
1.82
3.43
2.3
1.4
1.55
1.36
ratio
0.59
26
153
23
102
2.29
3.31
1.9
2.3
1.19
1.18
mmol/l
0.36
23
102
18
71
2.57
3.31
1.2
1.2
1.50
2.46
u/ml
—
10
26
33
173
1.94
3.13
1.5
1.6
—
—
—
0
0
12
35
3.46
3.11
2.3
2.6
1.00
1.03
index
0.04
12
35
24
112
2.17
3.08
2.2
1.4
1853.82
1463.68
e6/l
0.13
17
76
16
366
0.43
3.03
1.6
2.2
3.94
3.59
ratio
0.46
16
310
337
2879
1.27
2.98
3.2
3.4
1714.93
1830.94
ng/l
0.13
301
2524
90
627
1.48
2.98
4.0
3.8
4.91
5.20
kpa
2.92
80
596
5
5
10.04
2.98
10.2
1.0
20.60
15.80
u/ml
—
5
5
22
101
2.21
2.95
2.2
1.4
16506.15
38290.84
e6/l
0.52
13
56
13
46
2.85
2.92
1.5
1.9
12.85
15.56
umol/l
0.72
13
40
218
1767
1.31
2.90
1.9
1.8
447.87
21448880.45
pmol/l
1.21
176
1436
604
6509
0.79
2.86
11.2
7.5
44.72
40.92
mmol/mol
11.25
558
6014
42
246
1.74
2.84
2.0
1.4
0.00
0.00
g/l
-0.00
30
218
26
130
2.03
2.83
1.6
1.3
—
—
—
0
0
19
84
2.29
2.78
1.9
1.4
—
—
—
0
0
43
257
1.71
2.72
2.0
1.4
0.16
0.00
g/l
0.76
32
233
12
40
3.03
2.70
1.7
1.4
—
—
—
0
0
61
400
1.56
2.69
4.0
3.4
1.02
1.02
ratio
1.16
56
371
17
74
2.32
2.59
1.3
1.2
2.25
8.89
u/ml
0.74
12
38
51
324
1.61
2.57
2.2
1.4
3.03
2.98
g/l
0.15
41
283
26
135
1.95
2.57
1.5
1.3
—
—
—
0
0
11
36
3.08
2.57
1.7
1.5
—
—
—
0
0
48
303
1.62
2.49
2.0
1.4
1.00
0.41
g/l
0.49
34
258
76
532
1.47
2.49
3.7
3.6
1.31
2.08
mmol/l
0.94
45
387
9
26
3.49
2.48
1.0
1.0
1864.78
1674.88
miu/ml
—
9
26
53
347
1.56
2.38
2.2
1.4
7.70
7.42
g/l
0.51
43
305
8
22
3.66
2.36
3.9
3.3
—
—
—
0
0
23
119
1.96
2.32
1.6
1.3
—
—
—
0
0
366
3227
1.22
2.31
5.1
4.4
31.68
96.88
ng/l
2.44
321
2576
38
232
1.67
2.26
2.1
1.4
0.00
0.00
g/l
-0.00
29
217
7
18
3.91
2.25
2.6
1.3
—
—
—
0
0
15
66
2.29
2.25
2.4
2.3
—
—
—
0
0
568
6101
0.82
2.24
5.4
4.6
2.52
2.04
mu/l
6.50
509
5488
221
1851
1.26
2.23
4.8
3.4
0.00
0.00
estimate
0.80
82
568
40
249
1.63
2.22
1.6
1.8
51.23
38.16
u/l
1.92
32
204
5
9
5.58
2.21
1.4
1.1
119.20
103.56
%
—
5
9
52
346
1.53
2.19
2.2
1.4
4.29
3.69
g/l
2.13
43
305
52
347
1.53
2.17
2.2
1.4
4.38
4.08
g/l
2.43
43
306
11
42
2.64
2.14
1.0
1.0
—
—
—
0
0
11
42
2.64
2.14
1.7
1.4
—
—
—
0
0
21
109
1.95
2.11
6.9
4.5
13.91
10.97
pmol/l
0.39
21
109
5
10
5.02
2.07
1.0
1.0
—
—
—
0
0
67
922
0.71
2.04
1.2
1.3
24.44
12.76
u/ml
0.42
23
316
598
6353
0.83
1.91
41.5
16.5
74.35
73.22
ml/min/173m2
0.59
569
5900
74
989
0.73
1.90
1.2
1.3
38.22
40.26
iu/ml
0.04
27
280
9
34
2.66
1.87
1.1
1.5
—
—
—
0
0
9
34
2.66
1.87
1.1
1.5
—
—
—
0
0
9
35
2.59
1.80
1.4
1.3
—
—
—
0
0
9
35
2.59
1.80
1.4
1.3
—
—
—
0
0
6
18
3.35
1.75
1.5
1.2
11.73
9.95
ug/l
—
6
18
14
68
2.08
1.71
1.3
1.2
95.00
108.66
%
0.58
14
61
401
3642
1.18
1.70
4.9
3.7
0.00
0.00
estimate
-0.00
102
738
45
310
1.47
1.67
2.0
1.4
13.22
10.49
g/l
2.45
34
268
7
25
2.81
1.65
1.3
1.8
37.66
54.94
ug/l
—
7
25
38
255
1.51
1.60
1.2
1.2
11.01
117.98
u/ml
—
10
100
688
7179
0.83
1.59
61.0
25.1
124.39
136.46
g/l
54.29
671
7046
688
7178
0.83
1.58
63.2
25.4
37.49
40.53
%
35.80
670
7037
688
7178
0.83
1.58
60.5
24.9
193.28
231.19
e9/l
24.26
664
6965
688
7178
0.83
1.58
60.4
24.9
4.18
4.49
e12/l
32.06
664
6933
405
3698
1.17
1.58
5.0
3.7
12.24
0.00
estimate
0.50
105
752
42
289
1.48
1.58
1.9
3.0
—
—
—
0
0
688
7177
0.83
1.57
60.2
24.8
91.46
91.92
fl
1.33
671
7041
14
71
1.99
1.54
1.1
1.1
—
—
—
0
0
14
255
0.54
1.49
1.5
1.9
3.18
3.38
mmol/l
0.27
14
201
685
7139
0.84
1.49
53.3
22.5
90.36
88.24
umol/l
0.60
670
7016
405
3716
1.16
1.45
4.9
3.7
0.04
0.02
estimate
0.28
90
692
238
2096
1.18
1.42
5.1
3.7
0.00
0.00
estimate
0.50
83
651
87
690
1.29
1.41
3.0
2.2
0.63
0.41
e6/l
0.45
87
658
5
17
2.95
1.36
1.2
1.1
—
—
—
0
0
5
17
2.95
1.36
1.2
1.1
—
—
—
0
0
5
17
2.95
1.36
1.2
1.1
—
—
—
0
0
219
2478
0.85
1.35
1.8
1.8
16.67
19.27
nmol/l
2.25
196
2065
304
2746
1.16
1.32
5.1
3.7
0.00
0.01
estimate
1.08
91
615
43
584
0.72
1.28
1.3
1.4
—
—
—
0
0
11
55
2.01
1.27
1.4
1.1
—
—
—
0
0
11
56
1.98
1.22
2.5
1.5
—
—
—
0
0
458
4880
0.88
1.20
4.7
3.5
14.65
15.04
pmol/l
2.84
409
4349
28
191
1.48
1.15
1.4
1.4
—
—
—
0
0
28
191
1.48
1.15
1.4
1.4
—
—
—
0
0
14
234
0.59
1.14
1.1
1.5
19168.88
12500.62
e6/l
—
8
170
12
65
1.86
1.13
1.0
1.3
—
—
—
0
0
41
303
1.37
1.11
1.5
1.6
—
—
—
0
0
44
329
1.35
1.11
1.7
1.7
—
—
—
0
0
25
168
1.50
1.10
1.2
1.1
—
—
—
0
0
25
170
1.48
1.05
1.2
1.1
—
—
—
0
0
287
2621
1.14
1.04
2.1
2.2
189.74
291.76
u/l
1.38
272
2456
5
22
2.28
1.03
1.4
1.2
—
—
—
0
0
0
30
0.00
0.97
0.0
6.1
—
13.49
—
0
30
0
30
0.00
0.97
0.0
1.1
—
—
—
0
0
102
864
1.20
0.97
2.4
2.5
7.03
7.91
ug/l
0.19
84
756
684
6615
1.13
0.91
41.4
16.9
32.67
28.34
mg/l
2.69
663
5462
6
29
2.08
0.89
1.2
1.1
—
—
—
0
0
6
29
2.08
0.89
1.3
1.1
—
—
—
0
0
6
29
2.08
0.89
1.2
1.1
—
—
—
0
0
6
29
2.08
0.89
1.2
1.1
—
—
—
0
0
6
29
2.08
0.89
1.2
1.1
—
—
—
0
0
72
596
1.23
0.87
1.3
1.3
—
—
—
0
0
513
5369
0.90
0.87
53.0
22.1
331.23
332.75
g/l
2.87
508
5331
11
64
1.73
0.86
1.5
1.3
—
—
—
0
0
15
226
0.66
0.84
1.3
1.5
—
—
—
0
0
677
6973
0.89
0.83
35.1
10.6
43.01
26.34
u/l
36.96
662
6678
26
190
1.38
0.79
1.6
1.5
30.22
21.07
u/ml
—
5
33
0
25
0.00
0.79
0.0
2.9
—
10.37
—
0
25
0
25
0.00
0.79
0.0
2.9
—
5.21
—
0
25
685
7039
0.89
0.76
50.9
21.6
4.06
4.03
mmol/l
1.82
668
6870
9
55
1.64
0.73
1.2
1.2
—
—
—
0
0
9
55
1.64
0.73
1.2
1.2
—
—
—
0
0
9
55
1.64
0.73
1.2
1.2
—
—
—
0
0
82
952
0.85
0.72
4.5
5.4
31.49
32.48
%
0.36
63
602
21
151
1.40
0.71
1.2
1.3
0.62
0.81
nmol/l
0.97
14
129
5
26
1.93
0.70
1.8
1.1
791.60
220.55
iu/ml
—
5
26
685
7029
0.90
0.70
50.7
21.5
137.91
139.80
mmol/l
46.52
670
6865
550
5295
1.10
0.69
54.5
20.4
15.22
13.75
%
58.30
545
5198
40
320
1.26
0.69
3.9
4.2
23.27
24.87
mmol/l
3.01
35
289
11
69
1.60
0.68
1.5
1.3
—
—
—
0
0
15
215
0.69
0.68
1.1
1.1
—
—
—
0
0
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
14
200
0.70
0.63
1.4
1.5
—
—
—
0
0
29
227
1.29
0.60
2.7
2.2
118.87
132.55
g/l
2.64
23
184
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
17
123
1.39
0.58
1.2
1.3
—
—
—
0
0
10
65
1.54
0.55
1.1
1.2
—
—
—
0
0
17
227
0.74
0.54
1.7
1.3
—
—
—
0
0
310
2938
1.08
0.54
3.3
2.3
75.29
77.16
nmol/l
0.44
280
2559
11
74
1.49
0.53
1.2
1.2
0.32
0.20
nmol/l
0.70
11
61
13
180
0.72
0.51
1.1
1.2
—
100.37
—
0
6
9
64
1.41
0.51
1.4
1.2
—
—
—
0
0
62
707
0.87
0.48
2.7
2.3
12.68
15.47
nmol/l
1.18
50
629
7
50
1.40
0.45
1.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
13
96
1.36
0.41
1.5
1.5
—
—
—
0
0
13
96
1.36
0.41
3.8
4.6
—
—
—
0
0
8
58
1.38
0.41
1.5
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
15.42
—
0
6
0
15
0.00
0.41
0.0
1.1
—
16.22
—
0
9
26
213
1.23
0.41
1.2
1.2
—
—
—
0
0
8
59
1.36
0.41
1.5
1.2
—
—
—
0
0
8
59
1.36
0.41
1.5
1.2
—
—
—
0
0
8
61
1.31
0.39
1.0
1.1
—
—
—
0
0
17
214
0.79
0.38
1.9
1.9
201.00
213.29
pmol/l
0.25
17
202
522
5089
1.06
0.37
5.9
4.2
22.93
12.81
mm/h
19.61
479
4675
7
53
1.32
0.31
1.0
1.1
—
—
—
0
0
7
55
1.27
0.30
1.0
1.1
—
—
—
0
0
7
55
1.27
0.30
1.0
1.1
—
—
—
0
0
304
3144
0.95
0.29
2.7
2.3
—
—
—
0
0
8
63
1.27
0.28
1.5
1.2
—
—
—
0
0
8
64
1.25
0.27
1.5
1.2
—
—
—
0
0
8
65
1.23
0.27
1.0
1.5
—
210.00
—
0
10
376
3661
1.05
0.26
2.2
2.3
83.44
92.64
pmol/l
3.27
192
2006
5
73
0.68
0.26
1.0
1.1
—
81.80
—
0
5
10
126
0.79
0.24
1.1
1.2
—
63.83
—
0
12
5
38
1.32
0.23
1.2
1.0
—
—
—
0
0
5
38
1.32
0.23
1.2
1.0
—
—
—
0
0
15
125
1.20
0.22
1.0
1.1
—
1.88
—
0
9
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
6
50
1.20
0.19
1.0
1.2
—
—
—
0
0
11
90
1.22
0.19
1.3
1.2
2.11
20.87
nmol/l
0.45
11
84
166
1718
0.96
0.17
5.7
3.8
1.02
1.02
kg/l
0.09
118
1144
21
187
1.13
0.16
1.3
1.5
3.33
0.10
iu/ml
—
6
45
6
78
0.77
0.15
1.3
1.0
—
—
—
0
0
16
140
1.15
0.15
1.7
1.2
52.18
20.23
u/l
0.52
16
121
9
82
1.10
0.15
1.0
1.0
—
—
—
0
0
25
230
1.09
0.11
1.3
1.4
—
—
—
0
0
10
86
1.16
0.11
1.0
1.3
512.70
269.60
pmol/l
—
10
68
5
47
1.06
0.09
2.6
2.7
26.00
35.51
mg/l
—
5
39
7
64
1.09
0.08
1.0
1.2
—
1.37
—
0
6
7
66
1.06
0.08
1.0
1.1
—
—
—
0
0
27
254
1.06
0.08
1.1
1.7
7.23
8.18
iu/ml
—
7
56
16
173
0.92
0.06
1.0
1.2
—
—
—
0
0
94
958
0.98
0.05
14.0
7.0
—
—
—
0
0
16
159
1.01
0.00
1.7
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.17
—
0
6
0
5
0.00
-0.00
0.0
1.8
—
745.18
—
0
5
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
39.83
—
0
7
7
70
1.00
-0.00
1.0
1.1
—
15.75
—
0
13
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_HEPATOCELLU_CARC – Hepatocellular carcinoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).